Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serum Neurofilaments Light Chain and GFAP (Glial Fibrillary Acidic Protein) in Atypical Idiopathic Inflammatory Demyelinating Disorders

NCT04201470 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT04201470
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04201470 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serum Neurofilaments Light Chain and GFAP (Glial Fibrillary Acidic Protein) in Atypical Idiopathic Inflammatory Demyelinating Disorders
Lead sponsor
University Hospital, Montpellier
Phase
Not applicable
Overall status
Completed
Start date
December 9, 2019
Completion date
May 23, 2022
Enrollment
58 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

controls, multiple sclerosis, progressive multiple sclerosis, relapsing remitting multiple sclerosis